## ED: Consolidated Edison, Inc. - XLU: Utilities

### Executive Summary

No thesis match: MRS_10 -0.6% below STRENGTH zone (3.0-6.0%); PEG 3.33 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge. Caution: momentum weakening (-6.8% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($95.65)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 7
- **Sentiment:** Neutral (Bullish: 0, Bearish: 0)

**1. Morgan Stanley Maintains Underweight Rating On Consolidated Edison, Inc. (ED)**
- Source: Insider Monkey | 20251221T093100 | Somewhat-Bearish | Relevance: 100%
- Morgan Stanley has reiterated its Underweight rating on Consolidated Edison, Inc. (ED) and lowered its price target from $98 to $92, citing the significant impact of data centers on utility performance and growth for 2026. This follows a similar move by KeyBanc, which also reaffirmed an Underweight rating and reduced its price target due to political climate in New York and lack of growth prospects. Additionally, Consolidated Edison's subsidiary is selling its 6.6% stake in Mountain Valley Pipeline, LLC for $357.5 million, with the deal expected to close in the first half of 2026.

**2. Morgan Stanley Maintains Underweight Rating On Consolidated Edison, Inc. (ED)**
- Source: Yahoo! Finance Canada | 20251221T140809 | Somewhat-Bearish | Relevance: 100%
- Morgan Stanley reiterated its Underweight rating on Consolidated Edison, Inc. (ED) and revised its price target from $98 to $92, citing the significant impact of data centers on utility performance and growth for 2026. This follows a similar action by KeyBanc, which also maintained an Underweight rating and lowered its price objective due to political factors in New York and limited growth prospects. Consolidated Edison's subsidiary recently agreed to sell its 6.6% stake in Mountain Valley Pipeline for $357.5 million, with the deal expected to close in the first half of 2026.

**3. Middlesex Water appoints former Con Edison CFO to board**
- Source: Investing.com India | 20251222T220824 | Neutral | Relevance: 73%
- Middlesex Water Company announced the appointment of Robert Hoglund, former CFO of Consolidated Edison, to its Board of Directors effective January 1, 2026. Hoglund brings extensive experience in utility finance and corporate governance. The company, which provides water and wastewater services to over half a million people, has a strong dividend track record and analysts have set price targets ranging from $51 to $65.

**4. Middlesex Water appoints former Con Edison CFO to board By Investing.com**
- Source: Investing.com South Africa | 20251222T221408 | Somewhat-Bullish | Relevance: 70%
- Middlesex Water Company has appointed Robert Hoglund, former CFO of Consolidated Edison, Inc., to its Board of Directors, effective January 1, 2026. Hoglund brings extensive experience in utility finance, including mergers, acquisitions, and various financial matters. The company, which provides water and wastewater services in New Jersey and Delaware, highlights his expertise in governance, complex utility finance, and operational strategy as a key asset.

**5. Middlesex Water Company Appoints Robert Hoglund to Board of Directors**
- Source: GlobeNewswire | 20251222T164600 | Somewhat-Bullish | Relevance: 64%
- Middlesex Water Company has announced the appointment of Robert Hoglund to its Board of Directors, effective January 1, 2026. Mr. Hoglund brings extensive financial leadership experience, including over 18 years as CFO of Consolidated Edison, Inc., and will contribute to governance, utility finance, and operational strategy. The company highlighted his commitment to strengthening financial resilience and guiding organizations through complex industry challenges.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 0, Lowers: 3)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-17 | UBS | $104 | $112 | -7% |
| 2025-12-12 | JP Morgan | $97 | $101 | -4% |
| 2025-12-12 | Keybanc | $86 | $90 | -4% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-17 | UBS | main | Neutral |
| 2025-12-12 | JP Morgan | main | Underweight |
| 2025-12-12 | Keybanc | main | Underweight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **MIXED** |
| Buys | 2 ($0.15M) |
| Sells | 1 ($0.22M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 40.3% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 7 / 2 |

**Top Holders:**
- Vanguard Group Inc: 12.5% (+0.3%)
- Blackrock Inc.: 11.4% (-0.1%)
- State Street Corpora: 6.7% (+0.3%)
- Geode Capital Manage: 2.8% (+1.8%)
- Lazard Asset Managem: 1.7% (+121543.9%)

### Key Risks

1. Valuation stretched: PEG 3.3x requires aggressive growth execution.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 3.33 signals overvaluation risk, limited margin of safety. Forward P/E 16.4x stretched relative to 6% growth. Analyst sentiment negative (3 target cuts vs 0 raises). Institutional flow bullish (7 buying vs 2 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $35.7B |
| Beta | 0.36 |
| 52W Range | $87.28 - $114.87 |
| Short Interest | 2.9% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 3.33 |
| Forward P/E | 16.4 |
| Current P/E | 17.5 |
| YoY Growth | 6.4% |
| EPS Direction | STABLE |

### Technicals

MRS_10 deteriorating from 6.1% to -0.6% (-6.8% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 3.6pp (needs >3.0% for momentum thesis). Below SMA200 (0.97x), long-term trend not supportive. RSI neutral at 52. OFD pattern: +SBL (Volatile).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | -0.62% (CS: 58) | Neutral |
| RSI_14 | 52.1 | Neutral |
| MACD Histogram | 0.27 | Bullish |
| vs SMA20 | 1.011x | Above |
| vs SMA50 | 0.998x | Below |
| vs SMA200 | 0.968x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $98.95
- **Stop Loss:** $95.65 (3.3% risk)
- **Target:** $102.25 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 181
- **Position Value:** $17,909.95
- **Portfolio %:** 17.91%
- **Risk Dollars:** $600.00
- **Risk Per Trade:** 0.60%
- **Modifiers:** L1 120% | L2 50% | Combined 0.60x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.20x |
| L2 Sector | AVOID (Zone C) | 0.50x |

*NORMAL regime with moderate risk appetite in holiday-thinned conditions. VIX at 52-week lows suggests complacency, but modest breadth improvement and stable yields indicate underlying stability. Focus on quality positioning ahead of 2026 catalysts.*

### Earnings

**Next:** 2026-02-19 (Est: $0.86)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $1.75 | $1.90 | +8.3% |
| 2025Q2 | $0.66 | $0.67 | +1.8% |
| 2025Q1 | $2.21 | $2.26 | +2.4% |
| 2024Q4 | $0.96 | $0.98 | +2.1% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_10*